These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. Kussmann M, Schuster L, Zeitlinger M, Pichler P, Reznicek G, Wiesholzer M, Burgmann H, Poeppl W. Eur J Clin Microbiol Infect Dis; 2015 Nov; 34(11):2257-63. PubMed ID: 26337433 [Abstract] [Full Text] [Related]
5. Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids. Tobudic S, Poeppl W, Kratzer C, Vychytil A, Burgmann H. Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1327-34. PubMed ID: 22009289 [Abstract] [Full Text] [Related]
7. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams]. Saionji K. Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613 [Abstract] [Full Text] [Related]
8. Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections. Takla TA, Zelenitsky SA, Vercaigne LM. J Vasc Access; 2007 Oct; 8(4):262-7. PubMed ID: 18161672 [Abstract] [Full Text] [Related]
10. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo. Yao Q, Wang J, Cui T, Yang Z, Su M, Zhao P, Yan H, Zhan Y, Yang H. Molecules; 2016 Jan 06; 21(1):62. PubMed ID: 26751436 [Abstract] [Full Text] [Related]
12. Development of bacterial biofilms on silastic catheter materials in peritoneal dialysis fluid. Dasgupta MK, Ward K, Noble PA, Larabie M, Costerton JW. Am J Kidney Dis; 1994 May 06; 23(5):709-16. PubMed ID: 8172213 [Abstract] [Full Text] [Related]
13. Compatibility of Meropenem with Different Commercial Peritoneal Dialysis Solutions. Wiesholzer M, Winter A, Kussmann M, Zeitlinger M, Pichler P, Burgmann H, Reznicek G, Poeppl W. Perit Dial Int; 1994 May 06; 37(1):51-55. PubMed ID: 27605684 [Abstract] [Full Text] [Related]
17. Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions. Kussmann M, Ferth A, Obermüller M, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G. Sci Rep; 2019 Apr 24; 9(1):6512. PubMed ID: 31019280 [Abstract] [Full Text] [Related]
18. Comparison of peritoneal fluid culture results from adults and children undergoing CAPD. Yinnon AM, Gabay D, Raveh D, Schlesinger Y, Slotki I, Attias D, Rudensky B. Perit Dial Int; 1999 Apr 24; 19(1):51-5. PubMed ID: 10201341 [Abstract] [Full Text] [Related]
19. Glucose-based dialysis fluids inhibit innate defense against Staphylococcus aureus. Kumar PS, Mauriello CT, Hair PS, Rister NS, Lawrence C, Raafat RH, Cunnion KM. Mol Immunol; 2015 Oct 24; 67(2 Pt B):575-83. PubMed ID: 26256795 [Abstract] [Full Text] [Related]
20. Effect of Peritoneal Dialysis Fluids on Activity of Teicoplanin Against Methicillin-Resistant Staphylococcus aureus Biofilm. Tobudic S, Kern S, Kussmann M, Forstner C, Burgmann H. Perit Dial Int; 2019 Oct 24; 39(3):293-294. PubMed ID: 31088936 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]